# Grey Wolf Therapeutics (Grey Wolf Therapeutics Limited)

Private limited company registered in Abingdon, classed under “Research and experimental development on biotechnology”.

- Company number: 10989365
- Status: Active
- Type: Private limited company
- Incorporated: 29 September 2017
- Registered office: 99 Park Drive, Milton, Abingdon, OX14 4RY
- Location: Abingdon
- Activity: Research and experimental development on biotechnology
- Website: greywolftherapeutics.com

## Latest filed profit

Profit after tax in the year to 31 December 2024: **loss of £23m**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Grey Wolf Therapeutics do?

Private limited company registered in Abingdon, classed under “Research and experimental development on biotechnology”. In its own words: “Novel antigen modulation technology that controls T cells to guide the immune system”

### How much turnover does Grey Wolf Therapeutics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/grey-wolf-therapeutics-10989365

### Is Grey Wolf Therapeutics profitable?

No: it made a loss after tax of £23m in the year to 31 December 2024, its latest filed accounts.

### How many people work at Grey Wolf Therapeutics?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/grey-wolf-therapeutics-10989365

### Who runs and owns Grey Wolf Therapeutics?

Its directors are Paul John Grattan Stainer, Brenton Karl Ahrens, Thierry Hercend, Peter Joyce, Allan Patrick Marchington and 5 more. Its owners are shown to subscribers.

### Where is Grey Wolf Therapeutics based?

Its registered office is 99 Park Drive, Milton, Abingdon, OX14 4RY, in Abingdon.

### When was Grey Wolf Therapeutics founded?

Grey Wolf Therapeutics Limited was incorporated on 29 September 2017.

### Is Grey Wolf Therapeutics still trading?

The register lists Grey Wolf Therapeutics Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-10-23: Statement of capital following an allotment of shares on 21 October 2026 · GBP 3,063.8242 (and 19 more like it since 27 November 2020)
- 2026-10-22: Termination of appointment of Edwin Moses as a director on 30 September 2026
- 2026-09-14: Amended accounts for a small company made up to 31 December 2025
- 2026-08-26: Accounts for a small company made up to 31 December 2025
- 2026-08-17: Cancellation of shares. Statement of capital on 23 June 2026 · GBP 3,063.0773 (and 8 more like it since 26 October 2020)
- 2026-08-17: Purchase of own shares (and 5 more like it since 26 October 2020)
- 2026-07-29: Resolutions (and 12 more like it since 27 November 2020)
- 2026-04-24: Appointment of Mr Edwin Moses as a director on 16 April 2026
- 2026-03-11: Memorandum and Articles of Association (and 4 more like it since 27 November 2020)
- 2026-03-06: Appointment of Allan Marchington as a director on 2 March 2026
- 2026-03-04: Termination of appointment of Tracy Weightman as a director on 2 March 2026
- 2026-01-19: Replacement filing of SH01 - 02/06/25 Statement of Capital gbp 2987.4578
- 2025-12-19: Termination of appointment of Emma Johnson as a director on 10 December 2025
- 2025-12-15: Accounts for a small company made up to 31 December 2024
- 2025-06-03: Appointment of Mr Paul John Grattan Stainer as a secretary on 1 May 2025
- 2025-03-05: Termination of appointment of Samantha Ann Harris as a secretary on 1 March 2025
- 2024-12-02: Appointment of Dr Ekaterina Smirnyagina as a director on 25 November 2024
- 2024-11-29: Termination of appointment of Sally Marianne Dewhurst as a director on 25 November 2024
- 2024-08-29: Accounts for a small company made up to 31 December 2023
- 2024-06-13: Second filing of a statement of capital following an allotment of shares on 22 May 2024 · GBP 2,393.4229 (and 1 more like it since 8 April 2021)
- 2024-05-23: Appointment of Ms Tracy Weightman as a director on 15 May 2024
- 2023-06-30: Accounts for a small company made up to 31 December 2022
- 2023-01-20: Appointment of Ms Marie-Claire Peakman as a director on 23 December 2022
- 2023-01-19: Appointment of Miss Emma Johnson as a director on 23 December 2022
- 2023-01-19: Appointment of Dr. Sally Marianne Dewhurst as a director on 23 December 2022

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/grey-wolf-therapeutics-10989365